Vertex’s opioid-free drug for acute pain wins FDA approval
Nature Biotechnology, Published online: 17 February 2src25; doi:1src.1src38/s41587-src25-src259src-3Society, patients and clinicians welcome a much-needed non-opioid pain medication. Vertex’s first-in-class analgesic Journavx could soon be followed by a new generation of addiction-free pain drugs acting at NaV1.8 sodium channels…
Nature Biotechnology, Published online: 17 February 2src25; doi:1src.1src38/s41587-src25-src259src-3Society, patients and clinicians welcome a much-needed non-opioid pain medication. Vertex’s first-in-class analgesic Journavx could soon be followed by a new generation of addiction-free pain drugs acting at NaV1.8 sodium channels…
Read More
About Author
